Bob Hugin


March 2, 2015

Celgene Gives $10 Million to Myeloma Institute

Ben Boulden

March 2, 2015 | The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.


Celgene Gift to UAMS Myeloma Institute for Bart Barlogie Center for Molecular Diagnostics Advances the Course of Human Health for Patients with Multiple Myeloma

Ben Boulden

LITTLE ROCK –The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.